Literature DB >> 1588568

Bioreductive fluorescent markers for hypoxic cells: a study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead-nitrogen, bicyclic systems.

R J Hodgkiss1, R W Middleton, J Parrick, H K Rami, P Wardman, G D Wilson.   

Abstract

The oxygen-sensitive bioreductive binding of 2-nitroimidazoles labeled with fluorescent side chains has been used to stain hypoxic mammalian cells selectively. Several novel compounds were synthesized with a 1-substituent containing a fluorescent, bicyclic system having a bridgehead-nitrogen atom. Additional amine and secondary alcohol substituents were also included in the link between the fluorophor and the nitroimidazole to improve water solubility. Their ability to discriminate between hypoxic and oxic cells was compared by flow cytometric analysis. A wide range of cellular fluorescence and hypoxic-oxic differentials in fluorescence was observed when compounds with indolizine fluorophors were incubated with cells, and one such compound was considered suitable for further evaluation in vivo. Two compounds with bimane fluorophors gave very little cellular fluorescence when incubated with hypoxic cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588568     DOI: 10.1021/jm00088a030

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.

Authors:  Sandeep Apte; Frederick T Chin; Edward E Graves
Journal:  Curr Org Synth       Date:  2011-08       Impact factor: 1.975

2.  Biological reduction of nitroimidazole-functionalized gold nanorods for photoacoustic imaging of tumor hypoxia.

Authors:  Yui Umehara; Toki Kageyama; Aoi Son; Yu Kimura; Teruyuki Kondo; Kazuhito Tanabe
Journal:  RSC Adv       Date:  2019-05-29       Impact factor: 4.036

3.  Versatile nitro-fluorophore as highly effective sensor for hypoxic tumor cells: design, imaging and evaluation.

Authors:  Min Dai; Weiping Zhu; Yufang Xu; Xuhong Qian; Yan Liu; Yi Xiao; Yin You
Journal:  J Fluoresc       Date:  2008-01-12       Impact factor: 2.217

4.  Fluorescent property of 3-hydroxymethyl imidazo[1,2-a]pyridine and pyrimidine derivatives.

Authors:  Stephania Velázquez-Olvera; Héctor Salgado-Zamora; Manuel Velázquez-Ponce; Elena Campos-Aldrete; Alicia Reyes-Arellano; Cuauhtémoc Pérez-González
Journal:  Chem Cent J       Date:  2012-08-07       Impact factor: 4.215

5.  Indolizine-Based Scaffolds as Efficient and Versatile Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic Drugs.

Authors:  Marie Arvin-Berod; Agnès Desroches-Castan; Simon Bonte; Sabine Brugière; Yohann Couté; Laurent Guyon; Jean-Jacques Feige; Isabelle Baussanne; Martine Demeunynck
Journal:  ACS Omega       Date:  2017-12-27

Review 6.  The experimental development of bioreductive drugs and their role in cancer therapy.

Authors:  P Workman; I J Stratford
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

7.  Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].

Authors:  S M Evans; B Joiner; W T Jenkins; K M Laughlin; E M Lord; C J Koch
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.